Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
ABDL
Hmm. The only use for L is high TG. I’m sure some uneducated docs are also prescribing for RIt. It seems generic V would have to undercut GL
No way 15 to 20. 10 tops
ILT - you can go to Markmans website. They post their blogs
They update that periodically. It’s probably what Thero will use next week
So, the next possible hit we may take is when one of the scumbag generics launches. How low might we go then? Thoughts?
Well, that would be about $5 per share. Hopefully double that
Great idea!
Will - are you saying they gave a presentation to big/institutional investors after appeal but not us little guys? How do you know?
Thero usually talks the pps down about 50 cents or so
Yea, I’ve experienced the same with other companies.
Meows - Thx! Got any money I could borrow?
Thero still the CEO? Yep, we’re screwed
HDG - think you forgot a zero
Agree
What about Du saying USPTO did not consider Kura? Kura was listed as reference on the patent
Oh boy. Well, at least he can’t sink the price too much:)
North- think he’s referring to Du and appeal panel
Nor is mine, but I like your thinking!
Shoot, no idea on EU/Row. Though certainly more than current pps
So, time to turn out the lights?
You’re being too kind
Irish - good to see you!
Man, if I had a nickel for everyday this year that AMRN has nullified my other gains I’d be a wealthy man
Thx much!
RAise - what's Ekman's email address?
Not hit hard enough. All the Form 4 krap should be suspended
Love it!
Thx Kiwi
I would not expect anything from Thero. It's not his style to keep shareholders informed.
Suggest throwing in the fact that Du is an idiot and a liar. Idiot because she assumed studies on patients with one disease were applicable to patients with another. Liar because she said the patent office did not consider Kura (bald face lie).
Let's call a spade a spade.
They should. But I would not assume anything with our legal team. Look at the balls they dropped in the NV case. Not exactly the A team.
If not, might be a good buying opportunity?
Thx Rosey. What would A and B be in this case?
HK - interesting. So here, we’re talking infringement on RIt right?
What is meant by “infringing use was mandated by FDA requirements”?
Kiwi - On a serious note, I read yesterday that total US deaths to date are lagging 2017 by 1M. Total deaths in 2017 were 2.8M+. Doesn’t add up to me given all the “Covid deaths” this year.
Oops I forgot, Covid has cured heart disease and all other causes.
Not even the same planet.
Knowing AMRN's luck, it probably is.